Avanos Medical (AVNS) Gross Profit (2013 - 2026)

Avanos Medical (AVNS) has 14 years of Gross Profit data on file, last reported at $94.2 million in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit rose 4.9% year-over-year to $94.2 million; the trailing twelve-month figure through Mar 2026 stood at $358.3 million (down 4.78% YoY), and the FY2025 full-year result was $353.9 million, down 7.19% from the prior year.
• Gross Profit grew to $94.2 million in Q1 2026, from $86.0 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $106.6 million in Q1 2022 to a low of $86.0 million in Q3 2025.
• A 5-year average of $95.3 million and a median of $95.0 million in 2023 frame the typical range for Gross Profit.
• Across the five-year window, Gross Profit soared 218.58% in 2022 and fell 14.26% in 2023, its largest moves.
• Tracing AVNS's Gross Profit over 5 years: stood at $102.9 million in 2022, then fell by 7.68% to $95.0 million in 2023, then rose by 3.16% to $98.0 million in 2024, then decreased by 12.24% to $86.0 million in 2025, then rose by 9.53% to $94.2 million in 2026.
• Business Quant data shows AVNS's Gross Profit at $94.2 million in Q1 2026, $86.0 million in Q4 2025, and $86.0 million in Q3 2025.